0001916275-23-000001.txt : 20230706
0001916275-23-000001.hdr.sgml : 20230706
20230706154821
ACCESSION NUMBER: 0001916275-23-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
EFFECTIVENESS DATE: 20230706
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Incyclix Bio, LLC
CENTRAL INDEX KEY: 0001916275
IRS NUMBER: 850766611
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-439787
FILM NUMBER: 231073472
BUSINESS ADDRESS:
STREET 1: 600 PARK OFFICES DRIVE, SUITE 355
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (919) 328-0003
MAIL ADDRESS:
STREET 1: 600 PARK OFFICES DRIVE, SUITE 355
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: ARC Therapeutics, LLC
DATE OF NAME CHANGE: 20220309
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001916275
Incyclix Bio, LLC
600 PARK OFFICES DRIVE, SUITE 355
RESEARCH TRIANGLE PARK
NC
NORTH CAROLINA
27709
(919) 328-0003
DELAWARE
ARC Therapeutics, LLC
Limited Liability Company
true
2020
Fredric
N.
Eshelman
c/o Incyclix Bio, LLC
600 Park Offices Drive, Suite 355
Research Triangle Park
NC
NORTH CAROLINA
27709
Executive Officer
Director
Executive Officer and member of the Board of Managers.
Patrick
Roberts
c/o Incyclix Bio, LLC
600 Park Offices Drive, Suite 355
Research Triangle Park
NC
NORTH CAROLINA
27709
Executive Officer
Director
Executive Officer and member of the Board of Managers.
Sid
Subramony
c/o Incyclix Bio, LLC
600 Park Offices Drive, Suite 355
Research Triangle Park
NC
NORTH CAROLINA
27709
Director
Member of the Board of Managers.
Pharmaceuticals
Decline to Disclose
- 06b
true
0001916275-22-000002
2022-02-22
true
true
true
false
0
29999931
14952930
15047001
The offering is fully subscribed and the remaining $15,047,001 of the securities will automatically close upon the achievement of a specified milestone.
false
5
0
0
0
Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
false
Incyclix Bio, LLC
/s/ Patrick Roberts
Patrick Roberts
Chief Executive Officer
2023-07-06